REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,228,609$132,336,09410.69%
Essex Woodlands Management, Inc. 457,085$11,568,8218.76%
Ghost Tree Capital, LLC 525,000$13,287,7504.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 288,726$7,298,9932.22%
Evolutionary Tree Capital Management, LLC 59,411$1,503,6921.81%
Sio Capital Management, LLC 141,500$3,581,3650.91%
RICE HALL JAMES & ASSOCIATES, LLC 552,495$13,983,6550.79%
Integral Health Asset Management, LLC 250,000$6,327,5000.78%
Waypoint Capital Advisors, LLC 90,989$2,302,9320.72%
Polar Capital Holdings Plc 4,167,842$105,488,0810.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 870,000$22,019,7000.47%
RF&L WEALTH MANAGEMENT, LLC 20,000$506,2000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 108,860$2,755,2470.38%
Rhenman & Partners Asset Management AB 123,000$3,113,1300.33%
Neo Ivy Capital Management 23,952$6060.32%
Jackson Creek Investment Advisors LLC 29,839$7550.30%
SEVEN EIGHT CAPITAL, LP 70,697$1,789,3410.30%
Caption Management, LLC 569,800$14,421,6380.26%
Granahan Investment Management 288,927$7,312,7420.22%
Nebula Research & Development LLC 11,619$294,0770.22%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.